SFT2D2 Antikörper (N-Term)
Kurzübersicht für SFT2D2 Antikörper (N-Term) (ABIN954770)
Target
Alle SFT2D2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-30, N-Term
-
Spezifität
- Recognizes SFT2D2 (N-term).
-
Aufreinigung
- Protein A column followed by peptide Affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of Human SFT2D2 Genename: SFT2D2
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SFT2D2 (SFT2 Domain Containing 2 (SFT2D2))
-
Hintergrund
- PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. L-alpha-1-palmitoyl-2-linoleoyl phosphatidylethanolamine is more efficiently hydrolyzed than the other phospholipids examined.Synonyms: SFT2 domain-containing protein 2, Vesicle transport protein SFT2B
-
Gen-ID
- 375035
-
NCBI Accession
- NP_955376
Target
-